Literature DB >> 11342566

Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival.

D T Denhardt1, M Noda, A W O'Regan, D Pavlin, J S Berman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11342566      PMCID： PMC209291          DOI： 10.1172/JCI12980

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  38 in total

1.  The activation state of alphavbeta 3 regulates platelet and lymphocyte adhesion to intact and thrombin-cleaved osteopontin.

Authors:  O Helluin; C Chan; G Vilaire; S Mousa; W F DeGrado; J S Bennett
Journal:  J Biol Chem       Date:  2000-06-16       Impact factor: 5.157

2.  Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity.

Authors:  S Ashkar; G F Weber; V Panoutsakopoulou; M E Sanchirico; M Jansson; S Zawaideh; S R Rittling; D T Denhardt; M J Glimcher; H Cantor
Journal:  Science       Date:  2000-02-04       Impact factor: 47.728

3.  The integrin alpha(9)beta(1) binds to a novel recognition sequence (SVVYGLR) in the thrombin-cleaved amino-terminal fragment of osteopontin.

Authors:  Y Yokosaki; N Matsuura; T Sasaki; I Murakami; H Schneider; S Higashiyama; Y Saitoh; M Yamakido; Y Taooka; D Sheppard
Journal:  J Biol Chem       Date:  1999-12-17       Impact factor: 5.157

4.  Intracellular osteopontin is an integral component of the CD44-ERM complex involved in cell migration.

Authors:  R Zohar; N Suzuki; K Suzuki; P Arora; M Glogauer; C A McCulloch; J Sodek
Journal:  J Cell Physiol       Date:  2000-07       Impact factor: 6.384

5.  In vivo induction of insulin-like growth factor-I receptor and CD44v6 confers homing and adhesion to murine multiple myeloma cells.

Authors:  K Asosingh; U Günthert; M H Bakkus; H De Raeve; E Goes; I Van Riet; B Van Camp; K Vanderkerken
Journal:  Cancer Res       Date:  2000-06-01       Impact factor: 12.701

6.  Coupling of osteopontin and its cell surface receptor CD44 to the cell survival response elicited by interleukin-3 or granulocyte-macrophage colony-stimulating factor.

Authors:  Y H Lin; C J Huang; J R Chao; S T Chen; S F Lee; J J Yen; H F Yang-Yen
Journal:  Mol Cell Biol       Date:  2000-04       Impact factor: 4.272

7.  Regulation of no synthesis induced by inflammatory mediators in RAW264.7 cells: collagen prevents inhibition by osteopontin.

Authors:  J Y Tian; E S Sørensen; W T Butler; C A Lopez; M S Sy; N K Desai; D T Denhardt
Journal:  Cytokine       Date:  2000-05       Impact factor: 3.861

8.  Attenuated host resistance against Mycobacterium bovis BCG infection in mice lacking osteopontin.

Authors:  G J Nau; L Liaw; G L Chupp; J S Berman; B L Hogan; R A Young
Journal:  Infect Immun       Date:  1999-08       Impact factor: 3.441

9.  Osteopontin is induced by nitric oxide in RAW 264.7 cells.

Authors:  F Takahashi; K Takahashi; K Maeda; S Tominaga; Y Fukuchi
Journal:  IUBMB Life       Date:  2000-03       Impact factor: 3.885

10.  Abrogation of experimental colitis correlates with increased apoptosis in mice deficient for CD44 variant exon 7 (CD44v7).

Authors:  B M Wittig; B Johansson; M Zöller; C Schwärzler; U Günthert
Journal:  J Exp Med       Date:  2000-06-19       Impact factor: 14.307
View more
  314 in total

Review 1.  Regulation of interactions between cells and extracellular matrix: a command performance on several stages.

Authors:  E H Sage
Journal:  J Clin Invest       Date:  2001-04       Impact factor: 14.808

2.  Osteopontin contributes to TGF-β1 mediated hepatic stellate cell activation.

Authors:  Xiao Xiao; Yi Gang; Yong Gu; Lina Zhao; Jindong Chu; Jinfeng Zhou; Xiqiang Cai; Hui Zhang; Li Xu; Yongzhan Nie; Kaichun Wu; Zhiguo Liu; Daiming Fan
Journal:  Dig Dis Sci       Date:  2012-06-04       Impact factor: 3.199

3.  Identification of an IL-27/osteopontin axis in dendritic cells and its modulation by IFN-gamma limits IL-17-mediated autoimmune inflammation.

Authors:  Gopal Murugaiyan; Akanksha Mittal; Howard L Weiner
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-07       Impact factor: 11.205

4.  Osteopontin reduced hypoxia-ischemia neonatal brain injury by suppression of apoptosis in a rat pup model.

Authors:  Wanqiu Chen; Qingyi Ma; Hidenori Suzuki; Richard Hartman; Jiping Tang; John H Zhang
Journal:  Stroke       Date:  2011-01-27       Impact factor: 7.914

5.  Osteopontin deficiency enhances parathyroid hormone/ parathyroid hormone related peptide receptor (PPR) signaling-induced alteration in tooth formation and odontoblastic morphology.

Authors:  Maki Morishita; Noriaki Ono; Kentano Miyai; Tomomi Nakagawa; Ryo Hanyu; Masashi Nagao; Paksinee Kamolratanakul; Takuya Notomi; Susan R Rittling; David T Denhardt; Henry M Kronenberg; Yoichi Ezura; Tadayoshi Hayata; Tetsuya Nakamoto; Masaki Noda
Journal:  Tissue Cell       Date:  2011-04-21       Impact factor: 2.466

Review 6.  Matrix proteins.

Authors:  Caren M Gundberg
Journal:  Osteoporos Int       Date:  2003-08-29       Impact factor: 4.507

7.  The role of osteopontin and osteopontin aptamer (OPN-R3) in fibroblast activity.

Authors:  Cedric Hunter; Jennifer Bond; Paul C Kuo; Maria Angelica Selim; Howard Levinson
Journal:  J Surg Res       Date:  2011-08-27       Impact factor: 2.192

Review 8.  The impact of the extracellular matrix on inflammation.

Authors:  Lydia Sorokin
Journal:  Nat Rev Immunol       Date:  2010-10       Impact factor: 53.106

9.  Osteopontin, an oxidant stress sensitive cytokine, up-regulates collagen-I via integrin α(V)β(3) engagement and PI3K/pAkt/NFκB signaling.

Authors:  Raquel Urtasun; Aritz Lopategi; Joseph George; Tung-Ming Leung; Yongke Lu; Xiaodong Wang; Xiaodong Ge; Maria Isabel Fiel; Natalia Nieto
Journal:  Hepatology       Date:  2012-02       Impact factor: 17.425

10.  Cyclic Strain and Hypertension Increase Osteopontin Expression in the Aorta.

Authors:  Christa Caesar; Alicia N Lyle; Giji Joseph; Daiana Weiss; Fadi M F Alameddine; Bernard Lassègue; Kathy K Griendling; W Robert Taylor
Journal:  Cell Mol Bioeng       Date:  2016-12-27       Impact factor: 2.321
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.